Interactions with cells is our passion!

Learn how IgG 3-43 blocks tumor cell growth both in vivo and in vitro.

We offer cutting edge technology that provides our customers an advantage when developing new pharmaceuticals.

Our third generation biosensors’ technology is unique and patented.

It reduces animal testing and makes the drug development process more efficient and cost effective.

Swedish press releases including regulatory releases are available in our Swedish news room. The English newsroom can be found here.

Attana receives contract research order from European Biotech company
Attana has received an contract research order from an European Biotech company. The order is related to optimization of therapeutically antibodies. The order value is around 600 kSEK and is expected […]
New publication that elucidates Attana’s technology’s potential to predict drug efficacy
The publication "Improved Predictions of Drug Efficacy (https://content.yudu.com/web/15ex3/0A2nilh/EurolabJune2018/html/index.html?page=52&origin=reader)" in the June edition of Eurolab […]
New publication about applications of Attana's cell-based technology for characterization of drug molecules interaction with therapeutic receptors
Johan Rockberg and Johan Nilvebrant at KTH in Stockholm have edited a new book "Epitope Mapping Protocols (https://link.springer.com/book/10.1007/978-1-4939-7841-0)", which describes different […]

2018

June 18 to 20 - Advances in the Applications of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells

Attana to present scientific results at a conference for antibodies in clinical oncology on Cyprus. Welcome to listen or contact us for more information.

September 2 to 5 - CLINAM Summit

Attana are presenting recent discoveries of nanoparticles for therapeutic applications at the 11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine in Basel. Welcome to listen or contact us for more information.

Contact: info@attana.com

Greta Arwidssons v. 21, 114 19 Stockholm, Sweden.

Subscribe for information

Privacy statement | Terms of use

Interactions with cells is our passion!

Learn how IgG 3-43 blocks tumor cell growth both in vivo and in vitro.

Attana Cookies Policy